News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,830 Results
Type
Article (47369)
Company Profile (635)
Press Release (576817)
Multimedia
Podcasts (64)
Webinars (13)
Section
Business (163698)
Career Advice (2396)
Deals (31095)
Drug Delivery (126)
Drug Development (71870)
Employer Resources (143)
FDA (17256)
Job Trends (13556)
News (293905)
Policy (33503)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2659)
Academic (1)
Accelerated approval (27)
Adcomms (28)
Allergies (133)
Alliances (45014)
ALS (164)
Alzheimer's disease (1583)
Antibody-drug conjugate (ADC) (294)
Approvals (17495)
Artificial intelligence (537)
Autoimmune disease (125)
Automation (35)
Bankruptcy (306)
Best Places to Work (11200)
BIOSECURE Act (22)
Biosimilars (200)
Biotechnology (404)
Bladder cancer (153)
Brain cancer (58)
Breast cancer (610)
Cancer (4534)
Cardiovascular disease (386)
Career advice (2028)
Career pathing (35)
CAR-T (266)
CDC (49)
Celiac Disease (2)
Cell therapy (710)
Cervical cancer (37)
Clinical research (61695)
Collaboration (1617)
Compensation (747)
Complete response letters (56)
COVID-19 (2818)
CRISPR (85)
C-suite (681)
Cystic fibrosis (134)
Data (5851)
Decentralized trials (2)
Denatured (11)
Depression (136)
Diabetes (480)
Diagnostics (6544)
Digital health (45)
Diversity (9)
Diversity, equity & inclusion (35)
Drug discovery (248)
Drug pricing (197)
Drug shortages (28)
Duchenne muscular dystrophy (226)
Earnings (68257)
Editorial (55)
Employer branding (17)
Employer resources (129)
Events (84300)
Executive appointments (816)
FDA (20403)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (20)
Funding (1393)
Gene editing (189)
Generative AI (51)
Gene therapy (575)
GLP-1 (913)
Government (4911)
Grass and pollen (6)
Guidances (383)
Healthcare (17692)
HIV (54)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (196)
Immuno-oncology (52)
Indications (97)
Infectious disease (3081)
Inflammatory bowel disease (180)
Inflation Reduction Act (12)
Influenza (107)
Intellectual property (245)
Interviews (448)
IPO (15236)
IRA (49)
Job creations (2805)
Job search strategy (1668)
JPM (59)
Kidney cancer (12)
Labor market (75)
Layoffs (451)
Leadership (33)
Legal (7652)
Liver cancer (92)
Longevity (12)
Lung cancer (604)
Lymphoma (343)
Machine learning (43)
Management (48)
Manufacturing (795)
MASH (148)
Medical device (13597)
Medtech (13648)
Mergers & acquisitions (16888)
Metabolic disorders (1164)
Multiple sclerosis (149)
NASH (10)
Neurodegenerative disease (284)
Neuropsychiatric disorders (80)
Neuroscience (2732)
Neurotech (1)
NextGen: Class of 2026 (6410)
Non-profit (4308)
Now hiring (22)
Obesity (524)
Opinion (273)
Ovarian cancer (154)
Pain (205)
Pancreatic cancer (208)
Parkinson's disease (256)
Partnered (32)
Patents (497)
Patient recruitment (462)
Peanut (57)
People (45199)
Pharmaceutical (116)
Pharmacy benefit managers (31)
Phase 1 (18560)
Phase 2 (26765)
Phase 3 (21243)
Pipeline (4914)
Policy (285)
Postmarket research (2504)
Preclinical (7635)
Press Release (70)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (270)
Rare diseases (791)
Real estate (4995)
Recruiting (61)
Regulatory (25356)
Reports (45)
Research institute (2406)
Resumes & cover letters (398)
Rett syndrome (27)
RNA editing (16)
RSV (80)
Schizophrenia (139)
Series A (227)
Series B (178)
Service/supplier (23)
Sickle cell disease (86)
Special edition (23)
Spinal muscular atrophy (157)
Sponsored (44)
Startups (3224)
State (2)
Stomach cancer (20)
Supply chain (102)
Tariffs (95)
The Weekly (53)
Vaccines (1037)
Venture capital (69)
Weight loss (343)
Women's health (74)
Worklife (18)
Date
Last 7 days (534)
Last 30 days (1815)
Last 365 days (28004)
2026 (2618)
2025 (28450)
2024 (33118)
2023 (37236)
2022 (48159)
2021 (52133)
2020 (51147)
2019 (43966)
2018 (33757)
2017 (30915)
2016 (29367)
2015 (33627)
2014 (25223)
2013 (20680)
2012 (22442)
2011 (22733)
2010 (20242)
Location
Africa (815)
Alabama (70)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (38336)
Australia (6770)
California (10110)
Canada (2931)
China (1008)
Colorado (437)
Connecticut (455)
Delaware (321)
Europe (86408)
Florida (1578)
Georgia (347)
Hawaii (3)
Idaho (52)
Illinois (802)
India (65)
Indiana (469)
Iowa (24)
Japan (403)
Kansas (113)
Kentucky (30)
Louisiana (26)
Maine (73)
Maryland (1288)
Massachusetts (7219)
Michigan (295)
Minnesota (551)
Mississippi (6)
Missouri (134)
Montana (27)
Nebraska (22)
Nevada (108)
New Hampshire (83)
New Jersey (2908)
New Mexico (29)
New York (2750)
North Carolina (1383)
North Dakota (9)
Northern California (4775)
Ohio (304)
Oklahoma (18)
Oregon (44)
Pennsylvania (1941)
Puerto Rico (20)
Rhode Island (43)
South America (1078)
South Carolina (63)
South Dakota (1)
Southern California (3992)
Tennessee (161)
Texas (1598)
United States (36392)
Utah (306)
Vermont (1)
Virginia (269)
Washington D.C. (77)
Washington State (839)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
624,830 Results for "us worldmeds llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds
July 28, 2025
·
6 min read
FDA
US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk neuroblastoma.
December 14, 2023
·
6 min read
GLP-1
Baseline Debuts To Challenge GLP-1 Giant Lilly in Alcohol Use Disorder
While Baseline Therapeutics declined to disclose its starting capital, the startup said it will use the funds to push its GLP-1 asset BT-001 into late-stage development, with two trials planned this year.
January 27, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg
Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.
January 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Drug Development
Amgen and US WorldMeds: A Tale of Data and Two FDA Adcomm Meetings
Though data became an issue in two separate meetings, the FDA’s Oncologic Drugs Advisory Committee made a potentially precedent-setting decision by voting in favor of US WorldMeds’ neuroblastoma treatment.
October 6, 2023
·
2 min read
·
Greg Slabodkin
BioMidwest
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Panbela Therapeutics, Inc. (Nasdaq: PBLA) today announced that US WorldMeds®1 (USWM), a Kentucky-based specialty pharmaceutical company to whom it divested certain assets in its eflornithine pediatric neuroblastoma program, received FDA approval of its New Drug Application (NDA) for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients who have achieved at least a partial response to certain prior therapies.
December 18, 2023
·
8 min read
1 of 62,483
Next